FindTrial
Sign In

Effect of Sugammadex in patients on ventilator support

To study the clinical characteristics and duration of ventilator support in patients who received sugammadex during their ICU stay - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/093476
Enrollment
15
Registered
2025-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z991- Dependence on respirator

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Amarja Ashok Havaldar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients on invasive mechanical ventilation Patients received sugammadex

Exclusion criteria

Exclusion criteria: Patients who have not received sugammadex will be excluded

Design outcomes

Primary

MeasureTime frame
To assess the impact of sugammadex on the duration of mechanical ventilationTimepoint: 4 weeks—

Secondary

MeasureTime frame
The length of ICU stay in patients who received sugammadex.Timepoint: 1 week 4 weeks—

Countries

India

Contacts

Public ContactDr Amarja Havaldar

St Johns medical college

amarjahavaldar@rediffmail.com09036082112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026